Pituitary Function After Recovery From Septic Shock Among ICU Survivors
1 other identifier
observational
90
1 country
2
Brief Summary
Prolonged circulatory shock is associated with marked disturbances in vascular supply to the brain, and endothelial dysfunction which can lead to disseminated intravascular coagulation and microvascular thrombosis. Pituitary dysfunction is documented following post-partum hemorrhage, traumatic brain injury and subarachnoid hemorrhage, which also affect blood flow to the pituitary. However, there are no studies assessing pituitary function in the aftermath of recovery from shock. This will be a prospective observational study of patients admitted in Critical Care Medicine (CCM) ICU who have recovered from prolonged septic shock (Lasting for a period of \> 24 hours). Blood samples of the participants will be estimated at the time of discharge from the ICU and at 6 months post discharge. Investigators will estimate fasting serum cortisol, TSH, Free T4, Testosterone (in males), Oestrogen (in females), LH, FSH, Prolactin, IGF-1 and plasma ACTH in all participants at both time points (at the time of ICU discharge and at 6-months follow-up). Participants who have borderline serum cortisol values (138-400 nmol/l) will be subjected to 250ug ACTH stimulation test. Expected outcome of the proposed study is to know proportion of patients having pituitary hormone axis dysfunction. Investigators will also look for pituitary dysfunction persist or revert, or there are new onset dysfunction at 6 month follow up. This would have major implications in the follow up and management of ICU survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Start
First participant enrolled
August 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedOctober 15, 2024
October 1, 2024
1.9 years
July 30, 2023
October 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pituitary dysfunction at discharge
Frequency of dysfunction of various hypothalamo-pituitary hormone axes
Immediately before the ICU discharge
Secondary Outcomes (1)
Pituitary dysfunction at 6 months
Six months after the ICU discharge
Study Arms (2)
Septic shock group
Patients 18-80 years of age who meet the definition of septic shock. Vasopressor requirement should be maintained for a period \>24 hours and should require ICU stay for a duration of \> 7 days. Patient should recover from shock and be planned for discharge from the ICU.
Non-septic shock group
Patients 18-80 years of age who planned for discharge from the ICU.with stay for a duration of \>7 days. Also, they should not have received vasopressor for.a period of \>24 hours
Eligibility Criteria
Consecutive patients admitted to critical care medicine intensive care unit at Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow who meet the inclusion and exclusion criteria
You may qualify if:
- Septic shock group:
- Patients 18-80 years of age who meet the definition of septic shock.
- Vasopressor requirement should be maintained for a period \> 24 hours and should require ICU stay for a duration of \> 7 days.
- Patient should recover from shock and be planned for discharge from the ICU
- Non-septic shock group
- Patients 18-80 years of age who planned for discharge from the ICU.with stay for a duration of \>7 days.
- Also, they should not have received vasopressor for.a period of \>24 hours
You may not qualify if:
- Patients who refuse to provide consent.
- Age \<18 years or \> 80 years of age.
- Pregnancy or immediate post-partum (\< 6 months post-delivery).
- Chronic kidney disease (Stage 5), chronic liver disease (CHILD B or C), severe Chronic obstructive pulmonary disease, Chronic heart failure.
- Patients with pre-existing hypopituitarism on replacement.
- Past history of severe post-partum hemorrhage requiring blood transfusion, traumatic brain injury, subarachnoid hemorrhage, pituitary tumor/surgery, snake bite envenomation and meningo-encephalitis.
- Patients who have been on \> 5 mg prednisolone equivalent for a period of more than 2 weeks at any time in the previous 6 months before admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Critical Care Medicine, SGPGIMS
Lucknow, Uttar Pradesh, 226014, India
Department of Endocrinology, SGPGIMS
Lucknow, Uttar Pradesh, 226014, India
Biospecimen
Blood samples (8-10 ml) collected at the time of recruitment and at 6 months follow-up.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Subhash Yadav
Sanjay Gandhi Postgraduate Institute of Medical Sciences
- PRINCIPAL INVESTIGATOR
Mohan Gurjar
Sanjay Gandhi Postgraduate Institute of Medical Sciences
- PRINCIPAL INVESTIGATOR
Jayakrishnan C, DM
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 30, 2023
First Posted
August 14, 2023
Study Start
August 28, 2023
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share